TNSN06269A1 - SUBSTITUTED HETEROARYL AND PHENYLSULFAMOYL DERIVATIVES - Google Patents
SUBSTITUTED HETEROARYL AND PHENYLSULFAMOYL DERIVATIVESInfo
- Publication number
- TNSN06269A1 TNSN06269A1 TNP2006000269A TNSN06269A TNSN06269A1 TN SN06269 A1 TNSN06269 A1 TN SN06269A1 TN P2006000269 A TNP2006000269 A TN P2006000269A TN SN06269 A TNSN06269 A TN SN06269A TN SN06269 A1 TNSN06269 A1 TN SN06269A1
- Authority
- TN
- Tunisia
- Prior art keywords
- les
- des
- cholestérol
- taux
- pour
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La présente invention concerne des dérivés d'hétéroaryl- et phénylsulfamoyle substitués, des compositions pharmaceutiques contenant ces composés et l'utilisation de ces composés comme agonistes du récepteur d'activateur de prolifération d'un péroxysome (PPAR). Des activateurs de PPAR alpha, des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés pour élever les taux plasmatiques de certains lipides, comprenant le cholestérol - lipoprotéine haute densité et pour abaisser les taux plasmatiques de certains autres lipides, tels que le cholestérol - LDL et les triglycérides et en conséquences pour traiter des maladies qui sont exacerbées par de faibles taux de cholestérol - HDL et/ou avec de hauts taux de cholestérol - LDL et triglycérides, telles que l'athérosclérose et les maladies cardiovasculaires, chez des mammifères, y compris les êtres humains. Les composés sont également utiles pour le traitement de l'équilibre énergétique négatif (NEB) et des maladies associées chez les ruminants.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55211404P | 2004-03-10 | 2004-03-10 | |
PCT/IB2005/000526 WO2005092845A1 (en) | 2004-03-10 | 2005-02-28 | Substituted heteroaryl- and phenylsulfamoyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN06269A1 true TNSN06269A1 (en) | 2007-12-03 |
Family
ID=37859499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2006000269A TNSN06269A1 (en) | 2004-03-10 | 2006-09-08 | SUBSTITUTED HETEROARYL AND PHENYLSULFAMOYL DERIVATIVES |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1930121A (en) |
CR (1) | CR8567A (en) |
GT (1) | GT200500042A (en) |
TN (1) | TNSN06269A1 (en) |
ZA (1) | ZA200606597B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220220069A1 (en) * | 2017-08-10 | 2022-07-14 | Shanghai Jiaotong University School Of Medicine | Compound used as sirt6 small-molecule allosteric activator and pharmaceutical composition thereof |
CN109384694B (en) * | 2017-08-10 | 2022-04-05 | 上海爱乐维生物科技有限公司 | SIRT6 small-molecule agonist and application thereof |
-
2005
- 2005-02-28 CN CN 200580007622 patent/CN1930121A/en active Pending
- 2005-03-09 GT GT200500042A patent/GT200500042A/en unknown
-
2006
- 2006-08-08 ZA ZA200606597A patent/ZA200606597B/en unknown
- 2006-08-24 CR CR8567A patent/CR8567A/en not_active Application Discontinuation
- 2006-09-08 TN TNP2006000269A patent/TNSN06269A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200606597B (en) | 2007-10-31 |
CN1930121A (en) | 2007-03-14 |
GT200500042A (en) | 2005-10-24 |
CR8567A (en) | 2006-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN06447A1 (en) | SUBSTITUTED HETEROARYL AND PHENYLSULFAMOYL COMPOUNDS | |
MA27728A1 (en) | ANTAGONISTS OF CGRP RECEPTORS | |
TNSN06368A1 (en) | 3- (4-HETEROARYLCYCLOHEXYLAMINO) CYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS | |
TNSN05158A1 (en) | ASSOCIATION FOR THE TREATMENT OF ADHD | |
MA31151B1 (en) | MAPK / ERK KINASE INHIBITORS | |
EA200200118A1 (en) | β-CARBOLINE PHARMACEUTICAL COMPOSITIONS | |
DK0771197T3 (en) | Use of heterocyclic compounds as dopamine D3 ligands | |
MA32615B1 (en) | Cmet inhibitors | |
TNSN06038A1 (en) | 3,5-DISUBSTITUTED INDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MEDIATION OR INHIBITION OF CELL PROLIFERATION | |
TNSN08196A1 (en) | PYRAZINE DERIVATIVES | |
DK0544819T3 (en) | Indole derivatives which inhibit leukotriene biosynthesis | |
TNSN06347A1 (en) | MORPHOLINE DERIVATIVES | |
FI954944A (en) | Indole derivatives as 5-HT1-like agonists used in the treatment of migraine | |
WO2000059486A8 (en) | Use of cyp2d6 inhibitors in combination therapies | |
GB2408609A (en) | Modular financial service instrument | |
GB2394712A (en) | Fabrication of microstructured fibres | |
BR9406507A (en) | Composition of fuel or lubricant polt-1-n-alkenamines and application thereof | |
AU2003275613A1 (en) | Novel fructosyl peptide oxidase and utilization thereof | |
AR038207A1 (en) | ORIGINALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF AGOMELATINE | |
WO2004069152A3 (en) | Δ4,5 glycuronidase and uses thereof | |
MA26965A1 (en) | ASSOCIATION OF GABA AGONISTS AND ALDOSE-REDUCTASE INHIBITORS. | |
TNSN07100A1 (en) | DERIVATIVES OF 1, 2, 3, 4-TETRAHYDROQUINOLINE SUBSTITUTED IN POSITION 2 AND SUBSTITUTED 4-AMINO | |
MA31857B1 (en) | SUBSTITUTED N-PHENYL-PYRROLIDINYLMETHYLPYRROLIDINE-AMIDES AND THERAPEUTIC USE THEREOF | |
NO20014756D0 (en) | C (10) -heterosubstituted acetate toxans as antithrombotic agents | |
TNSN04225A1 (en) | BENZOXAZINE DERIVATIVES AS MODULATORS OF 5-HT6 AND USES THEREOF |